Mass Spectrom
A subcutaneous (Sub-Q) injection delivers the solution into the fatty layer just beneath the skin, allowing for slower absorption
Other signs it may be working include: Your appetite feels easy to manage day to day Cravings feel quieter compared to before treatment You feel able to stick to your usual routine without feeling intense hunger Your weight-related health markers (like blood sugar) stay improved Clinical trials have shown that people who continue taking tirzepatide are much more likely to maintain the weight they lost compared to those who stop treatment completely
It also has significant antioxidant effects and has been shown to inhibit carcinogenic receptor expression, which has led to research into its potential anti-tumor effects in breast and colorectal cancer [5, 6]
Brosseau JP, Liao CP, Wang Y, Ramani V, Vandergriff T, Lee M, et al
According to a case study by global insurance brokerage AssuredPartners, GLP-1 drug use reduced medical costs for users by roughly $560 per user per year